Addiction and Co-occurring Psychiatric Disorders

Learning Objectives

At the end of this activity learner should be more competent in the diagnosis and treatment of co-occurring psychiatric disorders and addiction, including:

  1. Distribution of co-occurring mental health disorders in substance use disorders;
  2. Impact of co-occurring mental health disorders on addiction treatment outcomes, particularly stratified by severity of mental illness as compared to severity of addiction;
  3. Best practices in integrated treatment for dual diagnosis (assessment, primary vs. secondary diagnoses, intensity & length of treatment services), including the role of treatment specifically within mental health only;
  4. Medication management for the common dual diagnoses, including role of treatment of anxiety during early recovery;
  5. Role of abstinence versus harm reduction in this group;
  6. Changes from DSM IV to DSM V in classifying co-occurring mental health disorders and substance use disorders.
Course summary
Available credit: 
  • 1.00 AAPA
  • 1.00 AMA Category 1
  • 1.00 CAADAC
  • 1.00 NCCAP
Course opens: 
09/15/2014
Course expires: 
08/31/2017
Cost:
$0.00
Rating: 
4

Richard Ries, MD
Dr. Richard Ries is Professor of Psychiatry at the University of Washington Medical School in Seattle, Washington. Dr. Ries serves as Associate Director of the University of Washington Addiction Psychiatry Residency Program. Dr. Ries is Director of Outpatient Psychiatry, Dual Disorder Programs, and the Chemical Dependency Project at Harborview Medical Center. He is director of substance abuse education at the University of Washington Medical School and director of the Division of Addictions for the Department of Psychiatry. Dr. Ries was chosen to chair the first official Treatment Improvement Protocol (TIP#9-1994) on dual disorders by the Center for Substance Abuse Treatment. He is the co-editor of the key reference text Principles of Addiction Medicine, published by the American Society of Addiction Medicine.

Dr. Ries is on the Speakers Bureau for Alkermes Pharma, Janssen Pharma:  and Reckitt Benckiser

Available Credit

  • 1.00 AAPA
  • 1.00 AMA Category 1
  • 1.00 CAADAC
  • 1.00 NCCAP

Accreditation Period

Course opens: 
09/15/2014
Course expires: 
08/31/2017

Price

Cost:
$0.00
Please login or register to take this course.